Articles

  • Oct 25, 2024 | dx.doi.org | Feifei Ren |Yanhua Yu |Haiyan Li |Chao Shen

    Published online by Cambridge University Press:  08 March 2024 Mingyao E [Opens in a new window] , Show author details Keywords Cardiac hypertrophylncRNAKCNQ1OT1miR-301bTcf7c-myc Type Original Article Information Cardiology in the Young , Volume 34 , Issue 7 , July 2024 , pp. 1493 - 1505 Copyright © The Author(s), 2024. Published by Cambridge University Press References 1 Gélinas, R, Mailleux, F, Dontaine, J, et al.

  • Oct 17, 2024 | onlinelibrary.wiley.com | Chenxi Lu |Yuan Liu |Feifei Ren |Haoran Zhang

    CONFLICT OF INTEREST STATEMENT The authors declare that they have no competing interests. REFERENCES , , , & (2014). Taurine ameliorates neuropathy via regulating NF-κB and Nrf2/HO-1 signaling cascades in diabetic rats. Food and Chemical Toxicology, 71, 116–121. , , , , & (2017). Induction of Nrf2-mediated phase II detoxifying/antioxidant enzymes in vitro by chitosan-caffeic acid against hydrogen peroxide-induced hepatotoxicity through JNK/ERK pathway.

  • May 7, 2024 | reuters.com | Feifei Ren |John Davis

    A Chinese flag flutters outside the China Securities Regulatory Commission (CSRC) building on the Financial Street in Beijing, China February 8, 2024. REUTERS/Florence Lo/File Photo May 07, 2024 - On Feb. 27, 2024, the People's Republic of China revised and broadened its State Secrets Law, opens new tab (Revised SSL) for the first time since 2010.

  • Nov 1, 2023 | mondaq.com | Feifei Ren

    Practical tips for multinational companies to prepare for challenging and evolving regulatory and enforcement landscape in the U.S. and China. In recent years, the rising tensions between the United States and China have resulted in an increasingly challenging and sometimes unpredictable environment for multinational companies (MNCs) with a presence in both countries.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →